2016 AFib Awareness Awards

The Heart Rhythm Society's AFib Awareness Awards provide selected HRS members with funding to support efforts that promote awareness of atrial fibrillation, patient compliance, caregiver awareness, diagnosis and treatment options, and the challenges of under-diagnosis of the disease. 

 

Award Recipients

HRS is pleased to offer three awards for up to $5,000 USD each to the following recipients: 

  • Jose Osorio, MD, Grandview Medical Center, Birmingham, AL, USA. Grandview Medical Center is launching a campaign for AFib awareness by involving the community, clinics, senior centers, and hospital facility. Their goals include community outreach, education to medical staff and directors, and a cardiac support group for patients and their families. 
  • Melissa Middeldorp, University of Adelaide, South Australia. Hearts4heart is a national organisation supporting, educating and advocating for Australians living with heart disease. Hearts4heart will coordinate a screening event at 36 pharmacy sites across Australia during the week from the 12th to the 18th of September. They will screen at least another 2,000 people and will use the week to profile the importance of improved screening, diagnosis and treatment for those affected by atrial fibrillation.
  • James E. Tisdale, PharmD, Purdue University, IN, USA. This program will screen individuals 65 years of age or older for AFib in a community pharmacy for a period of 8-12 weeks; screening approximately 200 individuals for AFib. Toward the end of the screening period, physicians, participating patients, and community pharmacists will be surveyed regarding their perceptions of the acceptability of performing AFib screening in community pharmacies. Qualitative data regarding feasibility and acceptability of AF screening will be analyzed by an investigator experienced in qualitative analyses. Depending on the analysis, the program could be expanded to other pharmacies.
 

HeartRhythm Case Reports Award Winners

HeartRhythm Case Reports received a unrestricted grant from Janssen Pharmaceuticals to cover the costs of publication for 6 Case Reports. All case reports submitted underwent peer review and were selected based upon merit. 

Award Winners

  1. Atrio-esophageal fistula is an uncommon complication of cryoballoon ablation. This case highlights the presentation, management, and discusses the pathophysiology related to esophageal injury.
  2. Radiation exposure during catheter ablation can increase risk of neoplasm. This case highlights the presentation, diagnosis, and management of a rare solitary bone plasmacytoma after atrial fibrillation ablation.
  3. Peri-ablation anticoagulation management in patients with heparin-induced thrombocytopenia or allergy is challenging. Larger profile ablation systems can increase risk of thromboembolism without effective anticoagulation. This case discusses the use of bivalirudin for anticoagulation during cryoballon ablation for atrial fibrillation.
  4. Is there a common pathologic link between WPW, Brugada Syndrome, and atrial fibrillation. This case report discussed the management of a patient with the combined arrhythmia syndromes and explores genetic associations.
  5. Simultaneous atrial fibrillation ablation and left atrial appendage closure remains a therapeutic approach requires additional investigation. This case highlights potential consequences of this combination approach when anticoagulation use is stopped early.
  6. Ablation of focal drivers in addition to pulmonary vein isolation remains a very active area of research to improve ablation outcomes in patients with more advanced atrial fibrillation subtypes. This cases highlights an interesting hierarchical approach using currently available tools that is the subject of an ongoing randomized trial.

This program is supported by an unrestricted grant from Janssen Pharmaceuticals, a Johnson and Johnson Company. 

Janssen Logo